NovaBay Pharmaceuticals, Inc. News Headlines

NBY 
$0.77
*  
unch
unch
Get NBY Alerts
*Delayed - data as of Aug. 27, 2014 9:40 ET  -  Find a broker to begin trading NBY now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    NBY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Why NovaBay Pharmaceuticals (NBY) Stock Plummeted to a One-Year Low Today
8/20/2014 1:12:00 PM - TheStreet

Behind The Promotion Of Northwest Bio
7/7/2014 9:35:00 AM - Seeking Alpha

Sector Update: Healthcare
11/7/2013 10:04:31 AM - MT Newswires

Sector Update: Healthcare Shares Mixed: NovaBay Sheds More than 50% on Failure to Meet Endpoint
11/7/2013 10:00:55 AM - MT Newswires

NovaBay: Phase II Topline Results For Auriclosene In UCBE Are Very Encouraging (NovaBay, $1.57)
9/16/2013 1:28:00 PM - Seeking Alpha

NovaBay: Data From Phase II Trial Of Auriclosene In Urinary Catheter Blockage And Encrustation Is Imminent
9/13/2013 9:56:00 AM - Seeking Alpha

NovaBay: Data From Phase II Trial Of Auriclosene In Urinary Catheter Blockage And Encrustation Is Imminent
9/13/2013 8:34:01 AM - SeekingAlpha

Second Half Of Year Offers Multiple Catalysts For NovaBay Pharmaceuticals
7/26/2013 10:24:00 AM - Seeking Alpha

NovaBay: Upcoming Auriclosene Data Could Be A Catalyst
6/11/2013 2:16:00 PM - Seeking Alpha

SmithOnStocks Opines: June 9, 2013
6/9/2013 10:25:00 PM - Seeking Alpha

NovaBay: Working On An Effective Treatment For Viral Conjunctivitis
4/13/2013 8:39:00 AM - Seeking Alpha

NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
3/18/2013 6:45:00 PM - Seeking Alpha

Novabay: A Novel Agent Against A Common Problem
2/20/2013 10:38:00 AM - Seeking Alpha

NovaBay's Sugar Daddy, Galderma, Pushes Impetigo Treatment
2/18/2013 7:10:00 AM - Seeking Alpha

Inside Trading Points To Promising New Development In NovaBay
2/12/2013 3:31:00 AM - Seeking Alpha

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It
2/6/2013 7:05:00 AM - Seeking Alpha

The Market Waits For NovaBay
1/24/2013 7:22:00 AM - Seeking Alpha

2 Highly Speculative Biotech Plays With Recent Insider Buying
1/14/2013 1:50:00 PM - Seeking Alpha

This Week's Biotech Summary (December 16-21, 2012)
12/19/2012 4:01:00 PM - Seeking Alpha

3 Healthcare Stocks With Recent Intensive Insider Buying
12/19/2012 12:25:00 PM - Seeking Alpha

NovaBay Swings For The Fences With NVC-422 Trial In Viral Conjunctivitis
11/30/2012 5:58:55 PM - SeekingAlpha

4 Longs And 1 Short To Consider
11/29/2012 3:46:00 PM - Seeking Alpha

NovaBay Pharmaceuticals Can Become A Potential Gold Mine
11/16/2012 10:57:00 AM - Seeking Alpha

For NovaBay, Simplicity Is The Father Of Invention
11/12/2012 9:23:00 AM - Seeking Alpha

China Biotech In Review: Singapore Company Completes Investment In NovaBay
11/11/2012 5:53:00 AM - Seeking Alpha